Choreo, LLC Natera, Inc. Transaction History
Choreo, LLC
- $7.23 Billion
- Q2 2025
A detailed history of Choreo, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Choreo, LLC holds 1,776 shares of NTRA stock, worth $343,158. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,776
Previous 1,781
0.28%
Holding current value
$343,158
Previous $251,000
19.52%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NTRA
# of Institutions
725Shares Held
125MCall Options Held
590KPut Options Held
246K-
Vanguard Group Inc Valley Forge, PA12.7MShares$2.45 Billion0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.2MShares$2.35 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$1.42 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.31 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.82MShares$932 Million3.66% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $18.7B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...